long covid

  1. John Mac

    Trial Report Insights into early recovery from Long COVID—results from the German DigiHero Cohort, Mikolajczyk et al, 2024

    Abstract 65 million people worldwide are estimated to suffer from long-term symptoms after their SARS-CoV-2 infection (Long COVID). However, there is still little information about the early recovery among those who initially developed Long COVID, i.e. had symptoms 4–12 weeks after infection but...
  2. Andy

    Protocol Personalized Management of Fatigue in Individuals With [ME/CFS] and [LC] Using a Smart Digital mHealth Solution:... 2024 Dorronzoro-Zubiete et al

    Full title: Personalized Management of Fatigue in Individuals With Myalgic Encephalomyelitis/Chronic Fatigue Syndrome and Long COVID Using a Smart Digital mHealth Solution: Protocol for a Participatory Design Approach Abstract Background:Fatigue is the most common symptom in myalgic...
  3. SNT Gatchaman

    Long COVID—ACOEM Guidance Statement, 2024, Stave et al.

    Long COVID—ACOEM Guidance Statement Stave, Gregg M.;Nabeel, Ismail;Durand-Moreau, Quentin Persistent symptoms are common after acute COVID-19, often referred to as long COVID. Long COVID may affect the ability to perform activities of daily living, including work. Long COVID occurs more...
  4. John Mac

    Trial Report Impaired Hand Grip Strength Correlates with Greater Disability and Symptom Severity in Post-COVID ME/CFS, Paffrath et al, 2024

    Full title: Impaired Hand Grip Strength Correlates with Greater Disability and Symptom Severity in Post-COVID Myalgic Encephalomyelitis/Chronic Fatigue Syndrome https://www.mdpi.com/2077-0383/13/7/2153 Abstract Post-COVID syndrome (PCS) encompasses a diverse array of symptoms persisting beyond...
  5. SNT Gatchaman

    Gas exchange abnormalities in Long COVID are driven by the alteration of the vascular component, 2024, Imeri et al.

    Gas exchange abnormalities in Long COVID are driven by the alteration of the vascular component Gianluca Imeri; Caterina Conti; Anna Caroli; Alberto Arrigoni ; Pietro Bonaffini; Sandro Sironi; Luca Novelli; Federico Raimondi; Greta Chiodini; Simone Vargiu; Fabiano Di Marco BACKGROUND There are...
  6. SNT Gatchaman

    “They seemed to be like cogs working in different directions”: a longitudinal qualitative study on Long COVID healthcare services in [UK], 2024, Fang+

    “They seemed to be like cogs working in different directions”: a longitudinal qualitative study on Long COVID healthcare services in the United Kingdom from a person-centred lens Fang, Chao; Baz, Sarah Akhtar; Sheard, Laura; Carpentieri, J. D. The COVID-19 pandemic has presented significant...
  7. SNT Gatchaman

    Brain and cognitive changes in patients with long COVID compared with infection-recovered control subjects, 2024, Serrano del Pueblo et al.

    Brain and cognitive changes in patients with long COVID compared with infection-recovered control subjects Serrano del Pueblo, Víctor M; Serrano-Heras, Gemma; Romero Sánchez, Carlos M; Piqueras Landete, Pepa; Rojas-Bartolome, Laura; Feria, Inmaculada; Morris, Richard G M; Strange, Bryan...
  8. ahimsa

    Vancouver, BC, Canada: Ed Yong Public Lecture on Long Covid (online attendance options)

    I don't know anything about this event other than what's at the link. https://www.eventbrite.ca/e/ed-yong-public-lecture-on-long-covid-tickets-849000241577 I am impressed by the mandatory safety protocols:
  9. SNT Gatchaman

    Hereditary Connective Tissue Diseases and Risk of Post-Acute SARS-CoV-2, 2024, Bartlett et al.

    Hereditary Connective Tissue Diseases and Risk of Post-Acute SARS-CoV-2 Bartlett, Maggie L.; Sova, Daniel; Jain, Mahim We completed a retrospective review of data collected by the JH-CROWN consortium based on ICD10 codes for a hospitalized cohort. The severity and prevalence of COVID-19 and...
  10. SNT Gatchaman

    Pituitary–Adrenal Axis and Peripheral Immune Cell Profile in Long COVID, 2024, Alijotas-Reig et al.

    Pituitary–Adrenal Axis and Peripheral Immune Cell Profile in Long COVID Alijotas-Reig, Jaume; Anunciacion-Llunell, Ariadna; Esteve-Valverde, Enrique; Morales-Pérez, Stephanie; Rivero-Santana, Sergio; Trapé, Jaume; González-García, Laura; Ruiz, Domingo; Marques-Soares, Joana; Miro-Mur, Francesc...
  11. SNT Gatchaman

    The Effect of Sex on the Risk of Long-COVID and Cardiovascular Complications in Healthy Patients without Comorbidities, 2024, Bielecka-Dabrowa et al.

    The Effect of Sex on the Risk of Long-COVID and Cardiovascular Complications in Healthy Patients without Comorbidities: Data from a Polish Long-COVID Cardiovascular PoLoCOV-CVD Study Bielecka-Dabrowa, Agata; Sakowicz, Agata; Gryglewska-Wawrzak, Katarzyna; Kapusta, Joanna; Banach, Maciej...
  12. SNT Gatchaman

    Brain temperature and free water increases after mild COVID-19 infection, 2024, Sharma et al.

    Brain temperature and free water increases after mild COVID-19 infection Sharma, Ayushe A.; Nenert, Rodolphe; Goodman, Adam M.; Szaflarski, Jerzy P. The pathophysiology underlying the post-acute sequelae of COVID-19 remains understudied and poorly understood, particularly in healthy adults with...
  13. SNT Gatchaman

    Post-COVID-19 condition: systemic inflammation and low functional exercise capacity, 2024, de Castro et al.

    Post-COVID-19 condition: systemic inflammation and low functional exercise capacity de Castro, Gabriela Salim; Gama, Leonardo R.; Ramos, Alexandre Ferreira; Gatti da Silva, Guilherme; Teixeira, Alexandre Abilio de Souza; Cunha-Neto, Edecio; de Souza, Heraldo Possolo; Marie, Suely K.; Talib, Leda...
  14. SNT Gatchaman

    Microfluidic Isolation of Neuronal-Enriched Extracellular Vesicles Shows Distinct and Common Neurological Proteins in LC, HIV & AD, 2024, Pulliam+

    Microfluidic Isolation of Neuronal-Enriched Extracellular Vesicles Shows Distinct and Common Neurological Proteins in Long COVID, HIV Infection and Alzheimer’s Disease Pulliam, Lynn; Sun, Bing; McCafferty, Erin; Soper, Steven A.; Witek, Malgorzata A.; Hu, Mengjia; Ford, Judith M.; Song, Sarah...
  15. SNT Gatchaman

    Blood Markers Show Neural Consequences of LongCOVID-19, 2024, Tang et al.

    Blood Markers Show Neural Consequences of LongCOVID-19 Tang, Norina; Kido, Tatsuo; Shi, Jian; McCafferty, Erin; Ford, Judith M.; Dal Bon, Kaitlyn; Pulliam, Lynn Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) persists throughout the world with over 65 million registered cases of...
  16. Wyva

    Higher level of physical activity reduces mental and neurological symptoms during and 2 years after COVID-19 infection in young women, 2024, Takács et

    Abstract Previous studies found that regular physical activity (PA) can lower the risk of SARS-CoV-2 (COVID-19) infection and post-COVID-19 condition (PCC), yet its specific effects in young women have not yet been investigated. Thus, we aimed to examine whether regular physical activity...
  17. Hutan

    Review Long Covid in Aotearoa NZ: Risk assessment and preventive action urgently needed, 2024, Kvalsvig et al

    https://www.phcc.org.nz/briefing/long-covid-aotearoa-nz-risk-assessment-and-preventive-action-urgently-needed On the Public Health Communication Centre Aotearoa Amanda Kvalsvig, Anna E. S. Brooks, John D. Potter, Mona Jeffreys, Julie Bennett, David Davies-Payne, Jonathan Kennedy, Dianne...
  18. SNT Gatchaman

    Age-related transcript changes in type I interferon signaling in children and adolescents with long COVID, 2024, Fracella et al.

    Age-related transcript changes in type I interferon signaling in children and adolescents with long COVID Matteo Fracella; Enrica Mancino; Raffaella Nenna; Chiara Virgillito; Federica Frasca; Alessandra D'Auria; Leonardo Sorrentino; Laura Petrarca; Domenico La Regina; Luigi Matera; Greta Di...
  19. SNT Gatchaman

    Opinion Is Low Cortisol a Marker of Long COVID?, 2024, Alaedini et al.

    Is Low Cortisol a Marker of Long COVID? Armin Alaedini; Stafford Lightman; Gary P. Wormser Cortisol is the primary glucocorticoid hormone produced by the adrenal glands, playing a critical role in multiple physiological processes, including metabolism, immune response regulation, cardiovascular...
  20. SNT Gatchaman

    Use of testosterone replacement therapy to treat long-COVID-related hypogonadism, 2024, Amodeo et al.

    Use of testosterone replacement therapy to treat long-COVID-related hypogonadism Alessandro Amodeo; Luca Persani; Marco Bonomi; Biagio Cangiano Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) can impair pituitary–gonadal axis and a higher prevalence of hypogonadism in...
Back
Top Bottom